Entecavir for patients with lamivudine-resistant chronic hepatitis B virus infection

To evaluate the benefits and harms of entecavir versus no intervention, placebo, and non-entecavir interventions in adults with lamivudine-resistant, chronic hepatitis B virus infection.

This is a protocol.

Share/Save